Literature DB >> 32905846

NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update.

William Small1, Walter R Bosch2, Mathew M Harkenrider3, Jonathan B Strauss4, Nadeem Abu-Rustum5, Kevin V Albuquerque6, Sushil Beriwal7, Carien L Creutzberg8, Patricia J Eifel9, Beth A Erickson10, Anthony W Fyles11, Courtney L Hentz3, Anuja Jhingran9, Ann H Klopp9, Charles A Kunos12, Loren K Mell13, Lorraine Portelance14, Melanie E Powell15, Akila N Viswanathan16, Joseph H Yacoub3, Catheryn M Yashar13, Kathryn A Winter17, David K Gaffney18.   

Abstract

PURPOSE: Accurate target definition is critical for the appropriate application of radiation therapy. In 2008, the Radiation Therapy Oncology Group (RTOG) published an international collaborative atlas to define the clinical target volume (CTV) for intensity modulated pelvic radiation therapy in the postoperative treatment of endometrial and cervical cancer. The current project is an updated consensus of CTV definitions, with removal of all references to bony landmarks and inclusion of the para-aortic and inferior obturator nodal regions. METHODS AND MATERIALS: An international consensus guideline working group discussed modifications of the current atlas and areas of controversy. A document was prepared to assist in contouring definitions. A sample case abdominopelvic computed tomographic image was made available, on which experts contoured targets. Targets were analyzed for consistency of delineation using an expectation-maximization algorithm for simultaneous truth and performance level estimation with kappa statistics as a measure of agreement between observers.
RESULTS: Sixteen participants provided 13 sets of contours. Participants were asked to provide separate contours of the following areas: vaginal cuff, obturator, internal iliac, external iliac, presacral, common iliac, and para-aortic regions. There was substantial agreement for the common iliac region (sensitivity 0.71, specificity 0.981, kappa 0.64), moderate agreement in the external iliac, para-aortic, internal iliac and vaginal cuff regions (sensitivity 0.66, 0.74, 0.62, 0.59; specificity 0.989, 0.966, 0.986, 0.976; kappa 0.60, 0.58, 0.52, 0.47, respectively), and fair agreement in the presacral and obturator regions (sensitivity 0.55, 0.35; specificity 0.986, 0.988; kappa 0.36, 0.21, respectively). A 95% agreement contour was smoothed and a final contour atlas was produced according to consensus.
CONCLUSIONS: Agreement among the participants was most consistent in the common iliac region and least in the presacral and obturator nodal regions. The consensus volumes formed the basis of the updated NRG/RTOG Oncology postoperative atlas. Continued patterns of recurrence research are encouraged to refine these volumes.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32905846      PMCID: PMC7856050          DOI: 10.1016/j.ijrobp.2020.08.061

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  42 in total

1.  Impact of post operative intensity modulated radiotherapy on acute gastro-intestinal toxicity for patients with endometrial cancer: results of the phase II RTCMIENDOMETRE French multicentre trial.

Authors:  Isabelle Barillot; Elsa Tavernier; Karine Peignaux; Danièle Williaume; Philippe Nickers; Magali Leblanc-Onfroy; Delphine Lerouge
Journal:  Radiother Oncol       Date:  2014-03-11       Impact factor: 6.280

2.  Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study.

Authors:  W T Creasman; C P Morrow; B N Bundy; H D Homesley; J E Graham; P B Heller
Journal:  Cancer       Date:  1987-10-15       Impact factor: 6.860

3.  Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy.

Authors:  Alexandra Taylor; Andrea G Rockall; Rodney H Reznek; Melanie E B Powell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-29       Impact factor: 7.038

4.  Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation.

Authors:  L Portelance; K S Chao; P W Grigsby; H Bennet; D Low
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-09-01       Impact factor: 7.038

5.  Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).

Authors:  Loren K Mell; Igor Sirák; Lichun Wei; Rafal Tarnawski; Umesh Mahantshetty; Catheryn M Yashar; Michael T McHale; Ronghui Xu; Gordon Honerkamp-Smith; Ruben Carmona; Mary Wright; Casey W Williamson; Linda Kasaová; Nan Li; Stephen Kry; Jeff Michalski; Walter Bosch; William Straube; Julie Schwarz; Jessica Lowenstein; Steve B Jiang; Cheryl C Saenz; Steve Plaxe; John Einck; Chonlakiet Khorprasert; Paul Koonings; Terry Harrison; Mei Shi; A J Mundt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-11-23       Impact factor: 7.038

6.  Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies.

Authors:  J C Roeske; A Lujan; J Rotmensch; S E Waggoner; D Yamada; A J Mundt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-12-01       Impact factor: 7.038

7.  Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.

Authors:  William Small; Loren K Mell; Penny Anderson; Carien Creutzberg; Jennifer De Los Santos; David Gaffney; Anuja Jhingran; Lorraine Portelance; Tracey Schefter; Revathy Iyer; Mahesh Varia; Kathryn Winter; Arno J Mundt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-26       Impact factor: 7.038

8.  MRI-Based Evaluation of the Vaginal Cuff in Brachytherapy Planning: Are We Missing the Target?

Authors:  Christina Hunter Chapman; Joann I Prisciandaro; Katherine E Maturen; Yue Cao; James M Balter; Karen McLean; Shruti Jolly
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-01-28       Impact factor: 7.038

9.  In reply to Keenan et al. Anatomic principles as the basis of target volume definition.

Authors:  Patricia J Eifel; Ann H Klopp
Journal:  Radiother Oncol       Date:  2018-09-29       Impact factor: 6.280

10.  Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.

Authors:  Stephanie M de Boer; Melanie E Powell; Linda Mileshkin; Dionyssios Katsaros; Paul Bessette; Christine Haie-Meder; Petronella B Ottevanger; Jonathan A Ledermann; Pearly Khaw; Alessandro Colombo; Anthony Fyles; Marie-Helene Baron; Ina M Jürgenliemk-Schulz; Henry C Kitchener; Hans W Nijman; Godfrey Wilson; Susan Brooks; Silvestro Carinelli; Diane Provencher; Chantal Hanzen; Ludy C H W Lutgens; Vincent T H B M Smit; Naveena Singh; Viet Do; Romerai D'Amico; Remi A Nout; Amanda Feeney; Karen W Verhoeven-Adema; Hein Putter; Carien L Creutzberg
Journal:  Lancet Oncol       Date:  2018-02-12       Impact factor: 41.316

View more
  14 in total

1.  A modified delineation method of para-aortic nodal clinical target volume in patients with locally advanced cervical cancer.

Authors:  Dunhuang Wang; Weiping Wang; Xiaoliang Liu; Kang Ren; Yongguang Liang; Qizhen Zhu; Fuquan Zhang; Ke Hu
Journal:  Cancer Med       Date:  2021-11-16       Impact factor: 4.452

2.  An Adversarial Deep-Learning-Based Model for Cervical Cancer CTV Segmentation With Multicenter Blinded Randomized Controlled Validation.

Authors:  Zhikai Liu; Wanqi Chen; Hui Guan; Hongnan Zhen; Jing Shen; Xia Liu; An Liu; Richard Li; Jianhao Geng; Jing You; Weihu Wang; Zhouyu Li; Yongfeng Zhang; Yuanyuan Chen; Junjie Du; Qi Chen; Yu Chen; Shaobin Wang; Fuquan Zhang; Jie Qiu
Journal:  Front Oncol       Date:  2021-08-19       Impact factor: 6.244

Review 3.  Advances in Radiation Oncology for the Treatment of Cervical Cancer.

Authors:  Mame Daro Faye; Joanne Alfieri
Journal:  Curr Oncol       Date:  2022-02-09       Impact factor: 3.677

4.  Half-beam volumetric-modulated arc therapy in adjuvant radiotherapy for gynecological cancers.

Authors:  Pei-Chieh Yu; Ching-Jung Wu; Hsin-Hua Nien; Louis Tak Lui; Suzun Shaw; Yu-Lun Tsai
Journal:  J Appl Clin Med Phys       Date:  2021-11-16       Impact factor: 2.102

Review 5.  Contemporary Fertility-Sparing Management Options of Early Stage Endometrioid Endometrial Cancer in Young Nulliparous Patients.

Authors:  Gulzhanat Aimagambetova; Sanja Terzic; Antonio Simone Laganà; Gauri Bapayeva; Philip la Fleur; Milan Terzic
Journal:  J Clin Med       Date:  2021-12-30       Impact factor: 4.241

6.  Prognostic Effect of Primary Recurrence Patterns in Squamous Cervical Carcinoma After Radical Surgery.

Authors:  Zongkai Zhang; Long Jiang; Rui Bi; Xiaohua Wu; Guihao Ke; Jun Zhu
Journal:  Front Oncol       Date:  2022-04-11       Impact factor: 5.738

7.  Age-Dependent Hematologic Toxicity Profiles and Prognostic Serologic Markers in Postoperative Radiochemotherapy Treatment for Uterine Cervical Cancer.

Authors:  Eva Meixner; Line Hoeltgen; Philipp Hoegen; Laila König; Nathalie Arians; Laura L Michel; Katharina Smetanay; Carlo Fremd; Andreas Schneeweiss; Jürgen Debus; Juliane Hörner-Rieber
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

8.  Mapping patterns of para-aortic lymph node recurrence in cervical cancer: a retrospective cohort analysis.

Authors:  Bong Kyung Bae; Shin-Hyung Park; Shin Young Jeong; Gun Oh Chong; Mi Young Kim; Jae-Chul Kim
Journal:  Radiat Oncol       Date:  2021-07-10       Impact factor: 3.481

9.  Effect of isocenter deviation on volume modulated arc therapy plan results and gamma passing rate in the treatment of cervical cancer.

Authors:  Yuan Yuan; Xiao-Bin Chang; Li-Juan Hu; Guo-Qing Wang; Yan-Jun Xue
Journal:  Transl Cancer Res       Date:  2021-10       Impact factor: 1.241

10.  Postoperative Radiotherapy for Endometrial Cancer in Elderly (≥80 Years) Patients: Oncologic Outcomes, Toxicity, and Validation of Prognostic Scores.

Authors:  Eva Meixner; Kristin Lang; Laila König; Elisabetta Sandrini; Jonathan W Lischalk; Jürgen Debus; Juliane Hörner-Rieber
Journal:  Cancers (Basel)       Date:  2021-12-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.